Elevation Oncology, Inc. - 28623U101
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q3 2025
· Q2 2025
Value (USD)
Total reported value ($000)
$220K
QoQ value delta ($000)
-$10.62M
(-97.97%)
Implied price effect (QoQ)
-0.0%
Shares
Total shares
600,810
QoQ shares delta
-28,990,380
(-97.97%)
Total shares held by funds (by quarter)
Top holders (Q3 2025)
Top 25 only
Full list
Partial Q3 2025 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| ExodusPoint Capital Management, LP | 219 | 597,017 | 0.0% |
| ROYAL BANK OF CANADA | 1 | 1,793 | 0.0% |
| OSAIC HOLDINGS, INC. | 0 | 2,000 | 0.0% |